Myelodysplastic Syndromes
📧 Sign up to get email alerts when something new happens for Myelodysplastic Syndromes.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Myeloablative Allogeneic Stem Cell Transplantation Using a Naive T-Cell Depleted Peripheral Blood Stem Cell Graft [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating myeloablative allogeneic stem cell transplantation with a naive T-cell depleted peripheral blood graft…
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: Phase I/II Trial of Sodium Stibogluconate in Myelodysplastic Syndrome [Phase 1]
A Phase I/II trial of sodium stibogluconate for myelodysplastic syndromes was terminated.
-
CLINICAL_TRIALS trial_result · 2013-11-07Clinical Trial Update: SCIO-469: Open-Label Study for Patients With Myelodysplastic Syndromes. [Phase 2]
A Phase 2 open-label study of SCIO-469 in patients with myelodysplastic syndromes has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: Arsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Leukemia, Chronic Myeloide Leukemia, Myelodysplasia, Lymphoma, or Myeloma [Phase 2]
A Phase 2 clinical trial update describes using arsenic trioxide to treat patients with recurrent or refractory acute leukemia, chronic myel…
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: Amifostine in Treating Patients With Advanced Myelodysplastic Syndrome [Phase 2]
Phase 2 clinical trial update evaluating amifostine for advanced myelodysplastic syndromes; current trial status is not provided.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-10-28Clinical Trial Update: Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia [Phase 3]
Phase 3 trial evaluating low-dose or high-dose conditioning regimens before peripheral blood stem cell transplantation in patients with myel…
-
CLINICAL_TRIALS withdrawal · 2013-10-01Clinical Trial Update: Study of Clofarabine in Combination With Low Dose Cytarabine to Treat Myelodysplastic Syndromes [Phase 2]
A Phase 2 trial evaluating clofarabine in combination with low-dose cytarabine for myelodysplastic syndromes has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Vorinostat and Idarubicin in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndromes [Phase 1]
A Phase 1 study evaluating the combination of vorinostat with idarubicin in patients with relapsed or refractory leukemia or myelodysplastic…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Tanespimycin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, or Myelodysplastic Syndromes [Phase 1]
Phase 1 trial evaluating Tanespimycin in combination with Cytarabine in adults with relapsed or refractory acute myeloid leukemia, acute lym…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: 7-Hydroxystaurosporine and Perifosine in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia or High Risk Myelodysplastic Syndromes [Phase 1]
Phase 1 trial of the combination therapy 7-Hydroxystaurosporine and perifosine in adults with relapsed or refractory acute leukemias, chroni…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: A Pharmacokinetic And Pharmacodynamic Study Of Oral Lenalidomide (Revlimid) In Subjects With Low- Or Intermediate-1-Risk Myelodysplastic Syndromes [Phase 1, Phase 2]
A pharmacokinetic and pharmacodynamic study of oral lenalidomide (Revlimid) in patients with low- or intermediate-1-risk myelodysplastic syn…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Decitabine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia [Phase 1]
Phase 1 trial of decitabine in patients with myelodysplastic syndromes or acute myeloid leukemia; the study status is terminated.
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: SJG-136 in Treating Patients With Relapsed or Refractory Acute Leukemia, Myelodysplastic Syndromes, Blastic Phase Chronic Myelogenous Leukemia, or Chronic Lymphocytic Leukemia [Phase 1]
Phase 1 trial of SJG-136 in relapsed or refractory hematologic cancers (acute myeloid leukemia subtypes, myelodysplastic syndromes, blast-ph…
-
CLINICAL_TRIALS trial_result · 2013-09-27Clinical Trial Update: Lenalidomide Maintenance Therapy in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML) [Phase 2]
A Phase 2 trial evaluating lenalidomide maintenance therapy in patients with myelodysplastic syndromes or acute myeloid leukemia was termina…
-
CLINICAL_TRIALS trial_result · 2013-09-20Clinical Trial Update: Combination Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia [Phase 3]
This entry reports a Phase 3 clinical trial evaluating combination chemotherapy in older patients with acute myeloid leukemia; the current s…
-
CLINICAL_TRIALS trial_result · 2013-09-18Clinical Trial Update: A Study of Decitabine Given Subcutaneously to Adults With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) [Phase 2]
Phase 2 study evaluating subcutaneous decitabine in adults with low- or intermediate-1 risk myelodysplastic syndromes has completed with pos…
-
CLINICAL_TRIALS trial_result · 2013-09-18Clinical Trial Update: To Demonstrate Superiority of Decitabine Over Azacitidine in Subjects With Intermediate- or High-risk MDS. [Phase 4]
A Phase 4 trial comparing decitabine with azacitidine in intermediate- or high-risk myelodysplastic syndromes was terminated, with results p…
-
CLINICAL_TRIALS trial_result · 2013-09-17Clinical Trial Update: Partially HLA-Matched Irradiated Allogeneic Cellular Therapy After Reduced Intensity Total Body Irradiation [Phase 1]
Phase 1 study of a partially HLA-matched irradiated allogeneic cellular therapy given after reduced-intensity total body irradiation; the tr…
-
FDA approval · 2013-09-16FDA Approved: AZACITIDINE — Original Application (Dr. Reddy's Laboratories Inc.)
FDA approved the original ANDA for azacitidine from Dr. Reddy's Laboratories Inc., enabling a generic version of the cancer drug. this appro…
-
CLINICAL_TRIALS trial_result · 2013-09-09Clinical Trial Update: Lenalidomide and Decitabine in High Grade Myelodysplastic Syndromes [Phase 1]
A Phase 1 trial evaluating lenalidomide plus decitabine in high-grade myelodysplastic syndromes has completed.
-
CLINICAL_TRIALS trial_result · 2013-09-02Clinical Trial Update: Study of Hypotensive Hematopoietic Malignancy Patients' USCOM Readings [NA]
A completed clinical trial update describing USCOM readings in patients with hematologic malignancies including leukemia, lymphoma, multiple…
-
CLINICAL_TRIALS trial_result · 2013-08-28Clinical Trial Update: SCRI Tissue Testing Registry
This trial update indicates the SCRI Tissue Testing Registry study has been terminated; it involved patients with melanoma, myelodysplastic …
-
CLINICAL_TRIALS trial_result · 2013-08-26Clinical Trial Update: Safety and Efficacy of Obatoclax Mesylate (GX15-070MS)for the Treatment of Myelodysplastic Syndromes (MDS) [Phase 2]
Phase 2 clinical trial assessing safety and efficacy of Obatoclax Mesylate (GX15-070MS) for treating Myelodysplastic Syndromes has completed…
-
CLINICAL_TRIALS trial_result · 2013-08-26Clinical Trial Update: Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes [Phase 2, Phase 3]
This clinical trial update notes a completed Phase 2/Phase 3 study evaluating combination chemotherapy with or without gemtuzumab ozogamicin…
-
CLINICAL_TRIALS research · 2013-08-26Clinical Trial Update: Early Diagnosis of Aspergillosis in Patients at High Risk of Fungal Infection Caused by Treatment for Hematologic Cancer or Other Disease [NA]
A clinical trial update on early diagnostic methods for aspergillosis in patients at high risk due to treatment for hematologic cancers or o…